• Epigenetic Activation of PDK1 Drives TKI Resistance in Cance

  2026-07-18

  This study reveals how epigenetic modifications via KDM3A and METTL16 elevate PDK1 expression, promoting resistance to EGFR tyrosine kinase inhibitors (TKIs) and facilitating cancer progression. The findings highlight a novel KDM3A/METTL16/PDK1 axis that may serve as a prognostic biomarker and therapeutic target, with implications for overcoming TKI resistance in oncology.

• Salmonella Haem Biosynthesis Suppresses Macrophage Phagocyto

  2026-07-17

  This study identifies a methyltransferase-driven mechanism by which Salmonella Typhimurium increases its haem biosynthesis, enabling evasion of macrophage phagocytosis and promoting infection in mice. The findings clarify a previously unrecognized regulatory axis in bacterial pathogenesis and offer new entry points for dissecting heme pathway contributions to immune evasion.

• Golgi-Tracker Green: Illuminating Golgi Stress and Dynamics

  2026-07-17

  Discover how Golgi-Tracker Green enables advanced live-cell Golgi apparatus labeling and dynamic analysis of organelle stress, bridging cutting-edge fluorescence technology with translational research. Unlock new insights into sphingolipid metabolism and cellular responses with this photostable BODIPY FL-labeled C5-ceramide probe.

• RSL3 as a Glutathione Peroxidase 4 Inhibitor in Cancer Assay

  2026-07-16

  Harnessing (1S,3R)-RSL3’s unique selectivity for GPX4 empowers researchers to dissect ferroptosis, synthetic lethality, and redox vulnerabilities in RAS-driven tumors. This guide translates bench protocols, workflow enhancements, and troubleshooting strategies to maximize experimental reliability and insight.

• Quantifying Methylated Purine Nucleosides via Stable Isotope

  2026-07-16

  This study introduces a highly sensitive and precise stable isotope-diluted UHPLC-MS/MS method to quantify ten methylated purine nucleosides, including 1-methyl Adenosine, in cellular models. The approach addresses analytical challenges in RNA modification research, enabling accurate biomarker discovery and advancing our understanding of purine metabolism in health and disease.

• Epalrestat in Neurodegeneration: Beyond Diabetic Complicatio

  2026-07-15

  Explore how Epalrestat, a potent aldose reductase inhibitor, is reshaping neurodegenerative disease research by targeting KEAP1/Nrf2 signaling and oxidative stress. Discover advanced insights and practical assay guidance for Parkinson’s disease and beyond.

• Structural Variants of A40926: Glycopeptide Activity and Spe

  2026-07-15

  This study systematically prepared and characterized aglycone and pseudoaglycone derivatives of A40926, a key dalbavancin precursor, to dissect the structural determinants of its antibacterial activity. The findings clarify how distinct glycopeptide moieties modulate efficacy against Gram-positive bacteria and Neisseria gonorrhoeae, providing a foundation for targeted antibiotic development.

• Heparin Sodium in Advanced Coagulation Workflows: Protocols

  2026-07-14

  Heparin sodium (SKU A5066) from APExBIO empowers researchers with reproducible, high-fidelity anticoagulation for thrombosis and blood coagulation pathway studies. This guide translates bench-proven protocols, cutting-edge delivery innovations, and troubleshooting strategies into actionable workflows, drawing on the latest research—including nanovesicle-mediated assay advances.

• BMAL1 Phase Separation Drives Circadian Transcriptional Hubs

  2026-07-14

  Gao et al. demonstrate that BMAL1, a core circadian clock protein, undergoes phase separation to form biomolecular condensates that regulate transcriptional timing. This discovery clarifies the mechanistic link between BMAL1’s structural properties and the robustness of circadian rhythms, highlighting a phosphorylation-tunable intrinsically disordered region as essential for hub formation and clock function.

• Benchmarking Sisomicin and Tobramycin Against Clinical Isola

  2026-07-13

  This article reviews a pivotal study comparing the in vitro activity of sisomicin, a new aminoglycoside antibiotic, with established agents such as tobramycin and gentamicin against over 560 clinical bacterial isolates. Key findings clarify relative potencies, resistance overlaps, and inform strategic antibiotic selection in microbiology research.

• N6-Methyl-dATP: Bridging Epigenetic Mechanisms to Translatio

  2026-07-13

  This thought-leadership article explores the mechanistic underpinnings and translational potential of N6-Methyl-dATP in DNA replication fidelity, epigenetic regulation, and disease modeling—particularly acute myeloid leukemia (AML). Anchored in recent mechanistic findings, the article provides strategic guidance for researchers seeking to harness N6-Methyl-2'-deoxyadenosine-5'-Triphosphate in advanced molecular biology, with actionable protocol parameters and a critical outlook on the clinical horizon.

• Gentamycin Sulfate: Mechanism, Evidence & Research Applicati

  2026-07-12

  Gentamycin Sulfate is a potent aminoglycoside antibiotic widely used in bacterial protein synthesis research. Its mode of action and rigorous benchmarks make it essential for studies on antibiotic resistance and ribosome function.

• Bufalin: Cardiotonics Transforming Cancer Research Workflows

  2026-07-10

  Bufalin is reshaping in vitro cancer research with its dual action as a cardiotonic steroid and potent apoptosis inducer. Recent peer-reviewed discoveries reveal its unique targeting of STK33 in triple-negative breast cancer, unlocking new avenues for precise, reproducible oncology workflows.

• Translational Impact of Ultra-Fast Coomassie Protein Stainin

  2026-07-09

  This article delivers a thought-leadership perspective on the mechanistic and strategic advances in protein visualization for translational research. Bridging insights from tumor microenvironment studies with next-generation staining techniques, it highlights how innovations like APExBIO's InstaBlue Protein Stain Solution enable rapid, sensitive, and mass spectrometry-compatible protein detection. The article contextualizes these advances within the challenges of disease modeling and biomarker discovery, offering protocol guidance and a forward-looking vision for clinical translation.

• Phalloidin (B7678): Technical Guidance for F-Actin Stabiliza

  2026-07-09

  Phalloidin (SKU B7678) is a cyclic heptapeptide toxin designed for high-affinity, selective stabilization and visualization of filamentous actin (F-actin) in fixed or permeabilized cell and tissue samples. It is not suitable for live-cell imaging or experiments requiring reversible actin dynamics. This article provides practical technical guidance for reliable cytoskeleton visualization and workflow execution.

452 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page